Enlivex Ltd. - (ENLV) closed at $0.17 on October 23, 2026, down 12.9% from the previous close, on volume of 513,261 shares (30-day average 1,811,870).
Data as of October 23, 2026.
23-Oct-2026
Enlivex to Implement 1-for-16 Reverse Share Split Effective October 27, 2026
TipRanks (Thu, 22-Oct 5:43 PM ET)
Enlivex announces 1-for-16 reverse stock split
Seeking Alpha News (Thu, 22-Oct 5:22 PM ET)
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
Globe Newswire (Thu, 22-Oct 5:16 PM ET)
Enlivex Slashes Costs and Workforce to Prioritize Phase 2b Knee Osteoarthritis Trial
TipRanks (Mon, 19-Oct 8:47 AM ET)
Globe Newswire (Mon, 19-Oct 8:17 AM ET)
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
Globe Newswire (Tue, 22-Sep 8:00 AM ET)
Globe Newswire (Thu, 30-Jul 8:00 AM ET)
Globe Newswire (Wed, 29-Jul 8:00 AM ET)
ENLV Secures $400 Million Private Placement—Major Bet on Prediction Markets and Longevity Medicine
Market Chameleon (Tue, 28-Jul 5:23 AM ET)
Enlivex Announces $400,000,000 Private Placement
Globe Newswire (Tue, 28-Jul 8:00 AM ET)
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Ltd. - trades on the NASDAQ stock market under the symbol ENLV.
As of October 23, 2026, ENLV stock price declined to $0.17 with 513,261 million shares trading.
ENLV has a beta of 0.54, meaning it tends to be less sensitive to market movements. ENLV has a correlation of 0.00 to the broad based SPY ETF.
ENLV has a market cap of $3.45 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ENLV traded as high as $68.85 and as low as $.17.
ENLV has underperformed the market in the last year with a price return of -98.9% while the SPY ETF gained +14.3%. ENLV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -96.0% and -31.7%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
ENLV support price is $.18 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENLV shares will trade within this expected range on the day.
